(Reuters) - The San Diego-based biotechnology company posted a net loss
of $45 million, or 34 cents per share, compared with a loss of
$46.4 million, or 38 cents per share, a year ago.
That matched analysts' average expectations, according to
Reuters Estimates.
Read more at Reuters.com Market News
of $45 million, or 34 cents per share, compared with a loss of
$46.4 million, or 38 cents per share, a year ago.
That matched analysts' average expectations, according to
Reuters Estimates.
Read more at Reuters.com Market News
No comments:
Post a Comment